Filing Details
- Accession Number:
- 0001181431-11-057117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-21 17:23:58
- Reporting Period:
- 2011-11-17
- Filing Date:
- 2011-11-21
- Accepted Time:
- 2011-11-21 17:23:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484478 | Furiex Pharmaceuticals Inc. | FURX | Pharmaceutical Preparations (2834) | 271197863 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1492646 | Frances Gail Mcintyre | C/O Furiex Pharmaceuticals, Inc. 3900 Paramount Parkway, Suite 150 Morrisville NC 27560 | Senior Vice President-Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-17 | 6,500 | $16.89 | 6,768 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | $13.16 | 2021-10-03 | 37,944 | 37,944 | Direct | |
| Common Stock | Stock Options (to buy) | $15.00 | 2021-05-09 | 26,000 | 26,000 | Direct | |
| Common Stock | Stock Options (to buy) | $9.11 | 2020-06-17 | 75,691 | 75,691 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2021-10-03 | 37,944 | 37,944 | Direct |
| 2021-05-09 | 26,000 | 26,000 | Direct |
| 2020-06-17 | 75,691 | 75,691 | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $16.60 to $16.99. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
- The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
- The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
Billionaire Hedge Funds
